- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| NVRI | ENVIRI CORP | 11.71% | 5,502,200 | $107,953,164 | 902,813 | 19.63% | $19.62 | 13F |
| TBPH | THERAVANCE BIOPHARMA INC | 8.52% | 4,841,629 | $78,579,639 | 541,629 | 12.6% | $16.23 | 13F |
| VISN | VISTANCE NETWORKS INC | 7.43% | 3,762,713 | $68,481,377 | 1,543,886 | 69.58% | $18.2 | 13F |
| QDEL | QuidelOrtho Corporation | 6.61% | 5,300,000 | $60,897,000 | 741,528 | 16.27% | 13G | |
| AIV | APARTMENT INVT & MGMT CO | 5.39% | 12,200,000 | $49,654,000 | 3,002,675 | 32.65% | $4.07 | 13F |
| PAR | PAR TECHNOLOGY CORP | 3.95% | 2,732,696 | $36,426,838 | 2,307,767 | 543.09% | $13.33 | 13F |
| CCOI | COGENT COMM HOLDINGS INC | 3.27% | 1,600,000 | $30,144,000 | 200,000 | 14.29% | $18.84 | 13F |
| MAGN | MAGNERA CORP | 2.85% | 2,760,000 | $26,247,600 | 400,000 | 16.95% | $9.51 | 13F |
| RCKT | ROCKET PHARMACEUTICALS INC | 1.23% | 3,165,900 | $11,333,922 | 515,900 | 19.47% | $3.58 | 13F |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 0.91% | 400,000 | $8,380,000 | 104,085 | 35.17% | $20.95 | 13F |
| MREO | MEREO BIOPHARMA GROUP PLC | 0.25% | 7,079,056 | $2,336,088 | 6,854,434 | 3051.54% | $0.33 | 13F |